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httpIntroduction: Dural venous sinus thrombosis (DVST) is a rare but potentially fatal cerebrovascular condition.
Pregnant women are at greater risk of DVST because of their hypercoagulable state.
Report: A 20-year-old post-partum woman presented to the emergency department after an episode of seizure
and complained only of a headache and chest pain. A T1-weighted magnetic resonance (MR) image of her brain
with contrast revealed an empty delta sign in her super sagittal sinus.
Discussion: Management of dural venous sinus thrombosis during or after pregnancy is a difﬁcult issue that
requires an approach based on the individual patient proﬁle.
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Dural venous sinus thrombosis (DVST) is a relatively rare
cerebrovascular complication but has the propensity to
cause substantial damage, including potentially fatal con-
ditions, such as hemorrhagic stroke. It affects about ﬁve
people per million and accounts for about 0.5e1% of all
strokes.1,2 There are many predisposing factors that may
contribute to the development of DVST. These include
cancer, hyperhomocysteinemia, iron deﬁciency anemia, folic
acid deﬁciency, systemic inﬂammatory diseases, anti-
thrombin III deﬁciency, C and S protein deﬁciency, mutation
of factor V Leiden, surgery, head trauma, and pregnancy
and puerperium.2,3 Pregnant women are at a greater risk
because of their hypercoagulable state, which persists
several weeks postpartum.4,5 The typical clinical pre-
sentations are headaches, seizures, focal neurological deﬁ-
cits, increased intracranial pressure, and possible
hemorrhage.1e4 The authors present a clinical case of DVST
during pregnancy and describe an effective management
strategy.
REPORT
A 20-year-old G5P1041 woman, with a recent Caesarean
delivery for a category 2 tracing, presented to the emer-
gency department with a headache and chest pain on
postoperative day 11 after one episode of a witnessed,
tonic-clonic seizure. Her postoperative course was compli-
cated by endometritis, which was treated with triple anti-
biotics. She then developed a Clostridium difﬁcile infection
and was discharged home on metronidazole. During herof original article: http://dx.doi.org/10.1016/j.ejvs.2014.05.006
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://dx.doi.org/10.1016/j.ejvsextra.2014.05.004postoperative period, she also had elevated blood pressure
and was discharged on hydrochlorothiazide. On the day of
presentation, she was normotensive with a pulse of 108
beats per minute. Physical examination was within normal
limits except for bilateral brisk triceps reﬂexes. A non-
contrast computed tomography (CT) scan of her head was
normal (Fig. 1). However, a T1-weighted magnetic reso-
nance (MR) image of her brain with contrast revealed an
empty delta sign in her superior sagittal sinus (Fig. 2). This is
a classic radiologic sign, in which a central hypointensity
due to very slow or absent ﬂow within the sinus is sur-
rounded by contrast enhancement in the surrounding
triangular shape in the posterior aspect of the superior
sagittal sinus. It can be seen as an upside down triangle in
the MR image. The central hypointensity represents the
clotted blood in the superior sagittal sinus.6 Additional
laboratory work to determine the cause of hypercoagula-
bility revealed a deﬁciency of protein S (50) and vitamin B12
(164). The patient was treated with anticoagulation therapy
and did not require further intervention.
DISCUSSION
Pregnant women have a greater risk for developing a dural
venous sinus thrombosis because of their hypercoagulable
state and other alterations in cardiovascular physiology.4,5
Fibrinogen, platelets, and factor levels (VII, VIII, IX, X, and
XII) are elevated, and ﬁbrinolytic activity is reduced.4 The
changes in maternal cardiovascular physiology during
pregnancy include increases in blood volume and cardiac
output. Pregnancy-related cerebral venous thrombosis has
also been reported in that the risk of peripartum central
venous thrombosis increased with increasing maternal age,
Cesarean delivery, as well as in the presence of hyperten-
sion, infections, and excessive vomiting in pregnancy.6,7
Several other lab tests were done in this patient to deter-
mine the cause of hypercoagulability, and it was found that
the patient was deﬁcient in protein S and vitamin B12.
Figure 1. Normal non-contrast head computed tomography (CT)
scan.
Figure 2. Abnormal T1-weighted magnetic resonance (MR) image
of brain with contrast, showing empty delta sign in superior
sagittal sinus.
e42 M. Shah et al.These can be low during pregnancy so this should be
investigated during the diagnostic process.8
In terms of the treatments for a DVST, the ﬁrst thera-
peutic strategy involves administration of anticoagulants
such as heparin and warfarin.1e6 It is imperative, however,
to use low-molecular-weight heparin over continuous
infusion heparin or oral warfarin when treating a pregnant
patient. Low-molecular-weight heparin does not cross the
placenta and may avoid teratogenic side-effects, which is
critical for the well-being of the fetus.2,8 Another impor-
tant factor to consider with anticoagulation therapy is the
potential consequence of intracranial hemorrhaging,
especially in pregnant women.4 If the patient is not
responding to anticoagulation therapy and is experiencing
neurological deﬁcits, the next step involves ﬁbrinolytic
drug therapy.2e4 This involves infusing clot-dissolving
agents, such as tissue plasminogen activator (tPA), strep-
tokinase (SK) or urokinase (UK), in the dural sinus via a
microcatheter. Long-term medical therapy for these pa-
tients includes systemic anticoagulation with warfarin for
an average of 6 months. Fortunately, the risk of DVST
recurrence during subsequent pregnancies is low.4 These
strategies must involve taking the necessary precautions
because pregnant women are at greater risk for hemor-
rhaging. Overall, several precautions must be taken, and a
multimodal therapeutic strategy tailored to the individual
patient is the best plan of action.FUNDING
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